Persons from racial and ethnic minority populations, those in low-income groups, and other socially marginalized groups are disproportionately affected by type 2 diabetes and experience higher disease prevalence, poorer glycemic control, higher rates of diabetes complications, and higher prevalence of comorbid conditions.1,2 Achieving glucose targets that will reduce the risk of diabetes complications, particularly among high-risk groups, is critical to improve the health and well-being of those with diabetes and to reduce health care utilization and expenditures. Yet, diabetes control remains elusive. Self-monitoring of blood glucose, while still a standard part of diabetes self-management, has not been shown to result in self-adjustments to insulin in primary care settings. This represents a significant opportunity gap because 30% of patients with type 2 diabetes are treated with some form of insulin.3
Peek ME, Thomas CC. Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes. JAMA. 2021;325(22):2255–2257. doi:10.1001/jama.2021.6208
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: